Actio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11202 El Camino Real Ste 100, San Diego,...Website
www.actiobiosciences.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Actio
Actio Biosciences, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, founded in 2021. The company uses human genetics, drug discovery, and data science to develop small-molecule precision therapeutics targeting the underlying biology of rare and common diseases. Its pipeline includes ABS-1230, a KCNT1 ion channel inhibitor for KCNT1-related epilepsy, and ABS-0871, a TRPV4 inhibitor being evaluated for Charcot-Marie-Tooth disease type 2C and overactive bladder.Explore more
Actio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Actio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Actio launches new products
Actio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Actio is spiking on competitors!
Check if Actio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Actio
Click to see if Actio had a recent Job posting/layoffs
Earning: See what the market has to say on Actio recently announced quarterly report
Funding: Get notified immidiatlly once Actio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Actio
Compare insights from companies similar to Actio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Actio financials insights
Gather financial insights about Actio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$55M
2025
Series B
$66M
Actio Tech Stack
A closer look at the technologies used by Actio
See more technologies
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Actio News & Media
Five Key Startups Shining the Light on Rare Diseases | Inside Precision Medicine
As investors flock to promising rare disease startups, check out our list of the top five investor favorites for their potential to bring new rare disease treatments to the market.Actio Biosciences to Participate in Evercore Emerging Private Biotech Conference
SAN DIEGO--(BUSINESS WIRE)--Actio Biosciences, a clinical-stage biotechnology company leveraging a novel approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that David Goldstein, Ph.D., co-founder and CEO, will present a company overview as part of the rare disease panel at the Evercore Emerging Private Biotech Conference on Monday, July 14, 2025, at 9:00 a.m. ET in Newport, Rhode Island.Actio Biosciences Raises $66 Million in Series B to Advance Genetics-Driven Therapeutics
Actio Biosciences has secured $66 million in a Series B […]Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven ...
Actio Biosciences, a clinical-stage biotechnology company leveraging a novel approach to genetics and precision medicine to develop new therapeutics that tar...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Actio
Sign Up For FreeTo access detailed company insights
Actio Biosciences, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, founded in 2021. The company uses human genetics, drug discovery, and data science to develop small-molecule precision therapeutics targeting the underlying biology of rare and common diseases. Its pipeline includes ABS-1230, a KCNT1 ion channe... Read More
